Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. (Q39215504)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56879589)
(Q46643038)
(Q114408547)
(P304) 1575-1581
(P407) (Q1860)
(P433) 10
(P478) 24
(P577) Monday, March 6, 2006
(P921) (Q715347)
(Q181600)
(Q29496)
(Q412323)
(P1433) (Q400292)
(P1476) "Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia" (language: en)
(P2093) Nicole Lamanna
Matt Kalaycio
Joseph G Jurcic
Mark Heaney
Renier Brentjens
Denise Horgan
Alison Gencarelli
David A Scheinberg
Mark A Weiss
other details
description scientific article

External Links